Novovax

COVID vaccine Novavax, developed in the US is all set to be launched in India with Serum Institute of India as its manufacturing partner. Novavax has passed the efficiency test with an impressive score of 90.4%. The trials of Novavax were conducted on 29,960 people in the US & Mexico, and have delivered positive results. Besides, it is named 'Covovax' in India and is currently in phase 2/3 bridging trails.